{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:56:29Z","timestamp":1790610989502,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project supported by Nanjing medical science and technology development fund","award":["YKK22253"],"award-info":[{"award-number":["YKK22253"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Although the COVID pandemic has gradually subsided, many patients have experienced complicated long-term symptoms, collectively known as \u201clong-COVID\u201d, which is commonly associated with persistent discomfort and decrease in quality of life. Individuals with immune-mediated inflammatory diseases, such as inflammatory bowel disease (IBD), are particularly vulnerable in the context of COVID infection, while the influence from \u201clong-COVID\u201d remains unrevealed. This cross-sectional study aims to assess health-related quality of life (HRQoL) among IBD patients with long COVID and to identify factors associated with HRQoL impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional survey was conducted from September 16 to October 10, 2023, among 235 IBD patients who had been treated at Nanjing BenQ Medical Center and Nanjing Jinling Hospital. The survey collected demographic data, COVID-19-related information, and HRQoL assessments using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Statistical analyses, including Chi-square tests, non-parametric tests, and multivariate linear regression, were employed to identify factors associated with long COVID and HRQoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 235 participants, 221 (94.04%) reported COVID-19 infection and 15 of 221 (6.79%) met the study definition of long COVID. Vaccination status differed by long-COVID status in an exploratory unadjusted comparison (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033); this finding was based on only 15 cases and was not adjusted for confounding. Participants with long COVID had a lower median SIBDQ score than those without long COVID (43.00 vs. 53.00;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). In the multivariable model, any post-COVID-19 symptoms and symptom duration were entered as nested indicators. A duration of \u2265\u20094 weeks was associated with an additional 8.52-point lower SIBDQ score beyond the association of any post-COVID-19 symptoms (B=-8.52; 95% CI, -13.85 to -3.18;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Participants meeting the study definition of long COVID reported lower HRQoL than those without long COVID. However, because validated IBD activity measures were not collected, the observed difference cannot be separated from the possible effect of underlying IBD activity. The vaccination finding is exploratory. Larger prospective studies with standardized disease-activity assessment are required to confirm these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-14323-1","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:24:04Z","timestamp":1788283444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health-related quality of life in IBD patients with long COVID under China\u2019s normalized COVID-19 management"],"prefix":"10.1186","volume":"26","author":[{"given":"Runnan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaogang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"1","key":"14323_CR1","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1038\/s41467-022-31897-x","volume":"13","author":"AIV S\u00f8rensen","year":"2022","unstructured":"S\u00f8rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, Meder IK, Ethelberg S, Hviid A. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13(1):4213.","journal-title":"Nat Commun"},{"issue":"8","key":"14323_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(23)00239-4","volume":"11","author":"M Parotto","year":"2023","unstructured":"Parotto M, Gy\u00f6ngy\u00f6si M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, Herridge MS. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739\u201354.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"14323_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12955-021-01862-1","volume":"19","author":"R Jandhyala","year":"2021","unstructured":"Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021;19(1):229.","journal-title":"Health Qual Life Outcomes"},{"issue":"31","key":"14323_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm7131a3","volume":"71","author":"L Kompaniyets","year":"2022","unstructured":"Kompaniyets L, Bull-Otterson L, Boehmer TK, et al. Post\u2013COVID-19 Symptoms and Conditions Among Children and Adults \u2014 United States, March 2020\u2013November 2021. MMWR Morb Mortal Wkly Rep. 2022;71(31):993\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"14323_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmii.2022.10.003","volume":"56","author":"CC Lai","year":"2023","unstructured":"Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect. 2023;56(1):1\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"14323_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","volume":"71","author":"CE Barrett","year":"2022","unstructured":"Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, Pavkov ME, Rolka DB, Wiltz JL, Bull-Otterson L, et al. Risk for Newly Diagnosed Diabetes\u2009>\u200930 Days After SARS-CoV-2 Infection Among Persons Aged\u2009<\u200918 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59\u201365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"14323_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/ecco-jcc\/jjaa205","volume":"15","author":"M Attauabi","year":"2021","unstructured":"Attauabi M, Poulsen A, Theede K, Pedersen N, Larsen L, Jess T, Rosager Hansen M, Verner-Andersen MK, K VH, Berg L\u00f8drup A, et al. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study. J Crohns Colitis. 2021;15(4):540\u201350.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"14323_CR8","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/gutjnl-2021-324356","volume":"70","author":"N Khan","year":"2021","unstructured":"Khan N, Mahmud N, Trivedi C, Reinisch W, Lewis JD. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System. Gut. 2021;70(9):1657\u201364.","journal-title":"Gut"},{"issue":"7","key":"14323_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1136\/gutjnl-2021-326784","volume":"71","author":"S Lin","year":"2022","unstructured":"Lin S, Lau LH, Chanchlani N, Kennedy NA, Ng SC. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2022;71(7):1426\u201339.","journal-title":"Gut"},{"issue":"2","key":"14323_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12049","volume":"9","author":"JF Ludvigsson","year":"2021","unstructured":"Ludvigsson JF, Axelrad J, Halfvarson J, Khalili H, Larsson E, Lochhead P, Roelstraete B, Simon TG, S\u00f6derling J, Ol\u00e9n O. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden. United Eur Gastroenterol J. 2021;9(2):177\u201392.","journal-title":"United Eur Gastroenterol J"},{"issue":"33","key":"14323_CR11","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.3748\/wjg.v27.i33.5520","volume":"27","author":"C Vigan\u00f2","year":"2021","unstructured":"Vigan\u00f2 C, Mulinacci G, Palermo A, Barisani D, Pirola L, Fichera M, Invernizzi P, Massironi S. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. World J Gastroenterol. 2021;27(33):5520\u201335.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"14323_CR12","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1093\/ibd\/izaa244","volume":"26","author":"C Vigan\u00f2","year":"2020","unstructured":"Vigan\u00f2 C, Massironi S, Pirola L, Cristoferi L, Fichera M, Bravo M, Mauri M, Redaelli AE, Dinelli ME, Invernizzi P. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy. Inflamm Bowel Dis. 2020;26(11):e138\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"1174","key":"14323_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/pmj-2022-141749","volume":"99","author":"R Golla","year":"2023","unstructured":"Golla R, Vuyyuru SK, Kante B, Kedia S, Ahuja V. Disorders of gut-brain interaction in post-acute COVID-19 syndrome. Postgrad Med J. 2023;99(1174):834\u201343.","journal-title":"Postgrad Med J"},{"issue":"2","key":"14323_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","volume":"163","author":"A Zollner","year":"2022","unstructured":"Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R\u00f6ssler A, Kimpel J, Adolph TE, Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163(2):495\u2013e506498.","journal-title":"Gastroenterology"},{"issue":"11","key":"14323_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3748\/wjg.v27.i11.1022","volume":"27","author":"JMF Chebli","year":"2021","unstructured":"Chebli JMF, Queiroz NSF, Dami\u00e3o A, Chebli LA, Costa MHM, Parra RS. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. World J Gastroenterol. 2021;27(11):1022\u201342.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"14323_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4240\/wjgs.v13.i7.702","volume":"13","author":"L Pirola","year":"2021","unstructured":"Pirola L, Palermo A, Mulinacci G, Ratti L, Fichera M, Invernizzi P, Vigan\u00f2 C, Massironi S. Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature. World J Gastrointest Surg. 2021;13(7):702\u201316.","journal-title":"World J Gastrointest Surg"},{"issue":"10","key":"14323_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cgh.2020.05.045","volume":"18","author":"S Massironi","year":"2020","unstructured":"Massironi S, Vigan\u00f2 C, Dioscoridi L, Filippi E, Pagliarulo M, Manfredi G, Conti CB, Signorelli C, Redaelli AE, Bonato G, et al. Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy. Clin Gastroenterol Hepatol. 2020;18(10):2375\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"22","key":"14323_CR18","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329(22):1934\u201346.","journal-title":"JAMA"},{"issue":"1","key":"14323_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12955-021-01890-x","volume":"19","author":"D Sun","year":"2021","unstructured":"Sun D, Chi L, Liu J, Liang J, Guo S, Li S. Psychometric validation of the Chinese version of the Short Inflammatory Bowel Disease Questionnaire and evaluation of its measurement invariance across sex. Health Qual Life Outcomes. 2021;19(1):253.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"14323_CR20","first-page":"1571","volume":"91","author":"EJ Irvine","year":"1996","unstructured":"Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial. Am J Gastroenterol. 1996;91(8):1571\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"14323_CR21","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/ibd\/izy099","volume":"24","author":"R Liu","year":"2018","unstructured":"Liu R, Tang A, Wang X, Shen S. Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers. Inflamm Bowel Dis. 2018;24(9):2039\u201347.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"14323_CR22","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10620-021-07118-8","volume":"67","author":"E Paulides","year":"2022","unstructured":"Paulides E, Pasma A, Erler NS, van Eijk RLA, de Vries AC, van der Woude CJ. Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2022;67(7):2849\u201356.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"14323_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12955-021-01698-9","volume":"19","author":"J Roseira","year":"2021","unstructured":"Roseira J, Sousa HT, Marreiros A, Contente LF, Magro F. Short Inflammatory Bowel Disease Questionnaire: translation and validation to the Portuguese language. Health Qual Life Outcomes. 2021;19(1):59.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"14323_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12876-024-03418-1","volume":"24","author":"R Wang","year":"2024","unstructured":"Wang R, Liu P, Fan C, Liu J, Jiang H, Ren J, Zhao Y, Zheng T. The impact of the COVID-19 surge after the end of China\u2019s Zero-COVID policy on the health-related quality of life of IBD patients. BMC Gastroenterol. 2024;24(1):312.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"14323_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn\u2019s Disease in Adults. Am J Gastroenterol. 2018;113(4):481\u2013517.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"14323_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, et al. ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment. J Crohns Colitis. 2020;14(1):4\u201322.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"14323_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/1751-2980.12994","volume":"22","author":"Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)","year":"2021","unstructured":"Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis. 2021;22(6):298\u2013317.","journal-title":"J Dig Dis"},{"key":"14323_CR28","doi-asserted-by":"publisher","first-page":"1783772","DOI":"10.3389\/fgstr.2026.1783772","volume":"5","author":"Y Li","year":"2026","unstructured":"Li Y, Chen C, Wang C. Current status of 5-aminosalicylic acid in Crohn\u2019s disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians. Front Gastroenterol (Lausanne). 2026;5:1783772.","journal-title":"Front Gastroenterol (Lausanne)"},{"issue":"3","key":"14323_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5217\/ir.2016.14.3.218","volume":"14","author":"SC Wei","year":"2016","unstructured":"Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res. 2016;14(3):218\u201323.","journal-title":"Intest Res"},{"issue":"30","key":"14323_CR30","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3748\/wjg.v28.i30.4102","volume":"28","author":"LY Yao","year":"2022","unstructured":"Yao LY, Shao BL, Tian F, Ye M, Li YQ, Wang XL, Wang L, Yang SQ, Lv XP, Jia Y, et al. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2022;28(30):4102\u201319.","journal-title":"World J Gastroenterol"},{"key":"14323_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2023.03.022","volume":"111","author":"F Ceban","year":"2023","unstructured":"Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, Lui LMW, Cao B, Mansur RB, Ho RC, et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav Immun. 2023;111:211\u201329.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"14323_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"14323_CR33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","volume":"41","author":"A Watanabe","year":"2023","unstructured":"Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783\u201390.","journal-title":"Vaccine"},{"issue":"1","key":"14323_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12955-023-02107-z","volume":"21","author":"I Mastrorosa","year":"2023","unstructured":"Mastrorosa I, Del Duca G, Pinnetti C, Lorenzini P, Vergori A, Brita AC, Camici M, Mazzotta V, Baldini F, Chinello P, et al. What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis. Health Qual Life Outcomes. 2023;21(1):28.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"14323_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(22)00126-6","volume":"10","author":"L Huang","year":"2022","unstructured":"Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863\u201376.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"14323_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12877-023-03757-w","volume":"23","author":"S Shanbehzadeh","year":"2023","unstructured":"Shanbehzadeh S, Zanjari N, Yassin M, Yassin Z, Tavahomi M. Association between long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023;23(1):40.","journal-title":"BMC Geriatr"},{"issue":"8","key":"14323_CR37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(22)00127-8","volume":"10","author":"Clinical characteristics with","year":"2022","unstructured":"Clinical characteristics with. inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761\u201375.","journal-title":"Lancet Respir Med"},{"key":"14323_CR38","doi-asserted-by":"publisher","first-page":"834844","DOI":"10.3389\/fmed.2022.834844","volume":"9","author":"D Cerasola","year":"2022","unstructured":"Cerasola D, Argano C, Corrao S. Lessons From COVID-19: Physical Exercise Can Improve and Optimize Health Status. Front Med (Lausanne). 2022;9:834844.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14323-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14323-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:10:18Z","timestamp":1790608218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14323-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14323"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14323-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our research has been approved by the Ethics Committee of Nanjing BenQ Medical Center, with the ethical approval number: 2023-KL022. Our research has been approved by the Ethics Committee of Nanjing BenQ Medical Center for exemption from informed consent. Our study adhered to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1728"}}